SEC 13F Intelligence

REATA PHARMACEUTICALS INC

CUSIP 75615P104

Reata Pharmaceuticals Inc has 1 institutional holders in Filings Flow’s 13F database, together reporting 12.2K shares worth $2M as of Q2 2020.

Institutional Holders
1
Q2 2020
Reported Value
$2M
Ticker
unmapped
private placement or foreign
Quarters Tracked
1

Ownership Trend

Institutional holders
Q2 ’20: 1Q2 ’20filingsflow.com
Total reported value
Q2 ’20: $2MQ2 ’20filingsflow.com

Holders

··
Manager% of PortfolioValueSharesQuarter
AM INVESTMENT STRATEGIES LLC$455M AUM0.75%$2M12.2KQ2 2020

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.